Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+12.16%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$43.2B
AUM Growth
+$461M
(+1.1%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-7.91%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
2,717
New
237
Increased
842
Reduced
1,328
Closed
286
Top Buys
| 1 |
Walmart
WMT
|
$461M |
| 2 |
Humana
HUM
|
$343M |
| 3 |
Pfizer
PFE
|
$292M |
| 4 |
Gilead Sciences
GILD
|
$286M |
| 5 |
Nike
NKE
|
$283M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$459M |
| 2 |
Merck
MRK
|
$348M |
| 3 |
Coinbase
COIN
|
$288M |
| 4 |
Rivian
RIVN
|
$279M |
| 5 |
Microsoft
MSFT
|
$277M |
Sector Composition
| 1 | Technology | 25.41% |
| 2 | Healthcare | 13.14% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.38% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Riskified
RSKD
$726M
| $136K | ﹤0.01% |
25,100
-42,800
| -63% | -$232K |
|
|
CNSL
2277
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $135K | ﹤0.01% |
31,325
+5,700
| +22% | +$24.6K |
|
|
CIO
2278
City Office REIT
CIO
$280M
| $134K | ﹤0.01% |
25,700
+12,500
| +95% | +$65.1K |
|
2279
Alto Ingredients
ALTO
$90.6M
| $134K | ﹤0.01% |
61,393
+43,093
| +235% | +$93.9K |
|
2280
Lipocine
LPCN
$15.7M
| $134K | ﹤0.01% |
25,722
-500
| -2% | -$2.6K |
|
|
ONL
2281
Orion Office REIT
ONL
$170M
| $133K | ﹤0.01% |
37,800
-16,400
| -30% | -$57.6K |
|
2282
NextCure
NXTC
$13M
| $129K | ﹤0.01% |
4,808
| – | – |
|
2283
Taboola.com
TBLA
$1,000M
| $128K | ﹤0.01% |
28,900
-200
| -0.7% | -$888 |
|
2284
BGSF Inc
BGSF
$68.6M
| $125K | ﹤0.01% |
12,000
-100
| -0.8% | -$1.04K |
|
|
EFXT
2285
Enerflex
EFXT
$1.22B
| $124K | ﹤0.01% |
+21,244
| New | +$124K |
|
2286
Omeros
OMER
$284M
| $121K | ﹤0.01% |
35,200
+14,100
| +67% | +$48.6K |
|
2287
Compass Therapeutics
CMPX
$590M
| $117K | ﹤0.01% |
59,300
-11,500
| -16% | -$22.8K |
|
2288
Heron Therapeutics
HRTX
$201M
| $117K | ﹤0.01% |
42,100
+3,100
| +8% | +$8.59K |
|
2289
Consumer Portfolio Services
CPSS
$172M
| $116K | ﹤0.01% |
15,400
-5,000
| -25% | -$37.8K |
|
2290
DocGo
DCGO
$155M
| $116K | ﹤0.01% |
+28,700
| New | +$116K |
|
2291
Cardiff Oncology
CRDF
$144M
| $116K | ﹤0.01% |
21,700
-17,500
| -45% | -$93.5K |
|
2292
BankFinancial
BFIN
$155M
| $116K | ﹤0.01% |
11,031
-2,600
| -19% | -$27.3K |
|
2293
China Yuchai International
CYD
$1.29B
| $116K | ﹤0.01% |
13,567
| – | – |
|
2294
MaxCyte
MXCT
$150M
| $115K | ﹤0.01% |
27,400
+4,900
| +22% | +$20.5K |
|
2295
Acacia Research
ACTG
$318M
| $114K | ﹤0.01% |
21,438
-31,800
| -60% | -$169K |
|
|
IMA
2296
ImageneBio, Inc. Common Stock
IMA
$89M
| $113K | ﹤0.01% |
+6,658
| New | +$113K |
|
2297
ALX Oncology
ALXO
$65.3M
| $112K | ﹤0.01% |
+10,000
| New | +$112K |
|
2298
OraSure Technologies
OSUR
$236M
| $109K | ﹤0.01% |
17,800
+2,600
| +17% | +$16K |
|
2299
Intellicheck
IDN
$107M
| $109K | ﹤0.01% |
31,300
-9,300
| -23% | -$32.4K |
|
2300
Protara Therapeutics
TARA
$122M
| $108K | ﹤0.01% |
27,018
| – | – |
|